ZHOU Hui, SHAN Shucan. Dosimetry and passing rate of forward-intensity modulated radiation therapy and intensity modulated radiation therapy for left breast cancer patients with breast conserving surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 15-18. DOI: 10.7619/jcmp.20200319
Citation: ZHOU Hui, SHAN Shucan. Dosimetry and passing rate of forward-intensity modulated radiation therapy and intensity modulated radiation therapy for left breast cancer patients with breast conserving surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 15-18. DOI: 10.7619/jcmp.20200319

Dosimetry and passing rate of forward-intensity modulated radiation therapy and intensity modulated radiation therapy for left breast cancer patients with breast conserving surgery

More Information
  • Received Date: November 11, 2020
  • Available Online: January 17, 2021
  • Published Date: January 14, 2021
  •   Objective  To compare the advantages and disadvantages of forward intensity modulated (f-IMRT) and intensity modulated radiation therapy (IMRT) plans for radiotherapy patients with left breast cancer undergoing breast conserving surgery.
      Methods  Eleven patients with left breast cancer undergoing conserving surgery were selected, Pinnacle3 Treatment Planning System(TPS) was used to design IMRT and f-IMRT planning. Dosimetric analysis was performed by TPS and the passing rate was analyzed using the Compass verification system, the strengths and weaknesses of the two plans were compared.
      Results  The results showed that the Planning Target Volume (PTV) and Argan at Risk (OAR) doses in both groups could meet the clinical requirements. The volume of the heart and the left lung exposed to 5 Gy dose (V5) and exposed to 30 Gy dose (V30) in the two plans and the values of mean dose (Dmean) of the left lung and the right lung were statistically significant (P < 0.05 orP < 0.01). The results of the passing rate analysis showed that both plans passed the verification under the standard of 3mm/3%, while only f-IMRT plan passed the verification under the standard of 2 mm/2%. The Gamma passing rates of PTV and OAR of the f-IMRT plan were significantly higher than those of the IMRT plan(P < 0.05 orP < 0.01).
      Conclusion  f-IMRT technology improves the plan passing rate while ensuring the clinical dose requirements, and may be considered as the first choice for routine radiotherapy of left breast cancer undergoing conserving surgery.
  • [1]
    陈万青, 郑荣寿, 张思维, 等. 2013年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2017, 26(1): 1-7. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201701001.htm
    [2]
    陈万青, 孙可欣, 郑荣寿, 等. 2014年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2018, 27(1): 1-14. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201801001.htm
    [3]
    孙可欣, 郑荣寿, 张思维, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201901001.htm
    [4]
    DARBY S, MCGALE P. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials[J]. Lancet, 2011, 378(9804): 1707-1716. doi: 10.1016/S0140-6736(11)61629-2
    [5]
    COZZOLINO M, OLIVIERO C, CALIFANO G, et al. Clinically relevant quality assurance(QA)for prostate RapidArc plans: Gamma maps and DVH-based evaluation[J]. Physica Medica, 2014, 30(4): 462-472. doi: 10.1016/j.ejmp.2014.01.003
    [6]
    International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photonbeam intensity-modulated radiation therapy(IMRT)[J]. Journal of the ICRU, 2010, 10(1): 1-106. http://www.ncbi.nlm.nih.gov/pubmed/24173332?report=medline&format=text
    [7]
    CLEMENTE F, PEREZ C. SU-E-T-77: Comparison of 2D and 3D Gamma Analysis in Patient-Specific QA for Prostate VMAT Plans[J]. Medical Physics, 2014, 41(6Part12): 239-239. doi: 10.1118/1.4888407
    [8]
    HUANG H, TSAI P, HUANG Y, et al. SU-E-T-183: Validation of COMPASS System for RapidArc Patient-Specific QA[J]. Medical Physics, 2011, 38(6): 3528. doi: 10.1118/1.3612133
    [9]
    SDROLIA A, BROWNSWORD K M, MARSDEN J E, et al. Retrospective review of locally set tolerances for VMAT prostate patient specific QA using the COMPASS® system[J]. Physica Medica, 2015, 31: 792-797. doi: 10.1016/j.ejmp.2015.03.017
    [10]
    GOLDBERG M, SUTRADHAR R, PASZAT L, et al. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis[J]. Breast Cancer Research and Treatment, 2019, 176(4): 657-667. doi: 10.1007/s10549-019-05266-0
    [11]
    HUANG X, CHEN Y, CHEN W, et al. Effect of radiotherapy after breast-conserving surgery in older patients with early breast cancer and breast ductal carcinomain situ: a meta-analysis[J]. Oncotarget, 2017, 8(17): 28215-28225. doi: 10.18632/oncotarget.15998
    [12]
    GUPTA S, KING W D, KORZENIOWSKI M, et al. The Effect of Waiting Times for Postoperative Radiotherapy on Outcomes for Women Receiving Partial Mastectomy for Breast Cancer: a Systematic Review and Meta-Analysis[J]. Clinical Oncology, 2016, 28(12): 739-749. doi: 10.1016/j.clon.2016.07.010
    [13]
    TSOUTSOU P G, KOUKOURAKIS M I, AZRIA D, et al. Optimal timing for adjuvant radiation therapy in breast cancer: A comprehensive review and perspectives[J]. Critical Reviews in Oncology/hematology, 2009, 71(2): 102-116. doi: 10.1016/j.critrevonc.2008.09.002
    [14]
    黎艳萍, 陈卫东, 廖玲霞. 早期乳腺癌保乳术及术后治疗的研究进展[J]. 医学综述, 2013, 19(1): 69-71. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZS201301026.htm
    [15]
    于金明, 李建彬. 乳腺癌保乳术后放射治疗进展[J]. 中华乳腺病志, 2007, 6(3): 13-22. https://www.cnki.com.cn/Article/CJFDTOTAL-SXZL201303073.htm
  • Related Articles

    [1]LI Ruibiao, REN Chengbo, WANG Cong, LI Yaru. Comparison of the efficacy of dosimetric parameters defined by different lung volume methods in predicting radiation pneumonitis in patients with non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 5-8, 13. DOI: 10.7619/jcmp.20221246
    [2]YUAN Meifang, YANG Yi, SUN Mengzhen, WEN Xiaobo, ZHAO Biao. Study on thyroid radiation dose of two intensity-modulated radiotherapy plans after radical mastectomy of left breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 16-19. DOI: 10.7619/jcmp.20213277
    [3]PAN Xiang, YANG Yi, HOU Yu, YUAN Meifang. Dosimetric differences of different radiation modes based on Monaco in postoperative intensity modulated radiotherapy of patients with left breast-conserving surgery for breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 1-5. DOI: 10.7619/jcmp.20200621
    [4]PAN Xiang, LI Ya, ZHU Sijin, YANG Yi. Dosimetry difference between field-in-field intensity modulated radiation therapy and fixed field inversely optimized intensity modulated radiation therapy in whole brain radiotherapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 12-16. DOI: 10.7619/jcmp.201919003
    [5]AN Xuehong, CAO Hekui, DUAN Shuhao. Effect of spiral fault fixed field intensity modulated radiation therapy on esophageal cancer in middle segment[J]. Journal of Clinical Medicine in Practice, 2018, (11): 101-103. DOI: 10.7619/jcmp.201811028
    [6]LIU Wanjun, ZHANG Xizhi, LI Jun, HUA Wei, ZHANG Xianwen, CHEN Xuemei. Effects of dose calculation algorithm on dosiology of breast cancer patients with intensity modulated radiation therapy[J]. Journal of Clinical Medicine in Practice, 2016, (15): 28-32. DOI: 10.7619/jcmp.201615008
    [7]SONG Chengxia, WANG Jing. Dosimetric study of volumetric modulated arc therapy and intensity modulated radiation therapy in postoperative radiotherapy of cervical carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (23): 75-77,81. DOI: 10.7619/jcmp.201523023
    [8]LIU Wanjun, ZHANG Xizhi, LI Jun, ZHANG Xianwen, CHEN Xuemei, GUI Longgang. Dosimetry comparison between cyberknife and gamma knife plan for patients with small tumors of lung[J]. Journal of Clinical Medicine in Practice, 2015, (21): 63-65. DOI: 10.7619/jcmp.201521017
    [9]LI Jinkai, CAO Yuandong, LI Caihong, WANG Peipei, SUN Xinchen. Application of volumetric modulated radiation therapy in the radiotherapy of patients with left breast cancer after breast-conserving surgery[J]. Journal of Clinical Medicine in Practice, 2015, (21): 59-62. DOI: 10.7619/jcmp.201521016
    [10]XU Ming, JUN Liang. Effect comparison between Gamma3 nail and PFNA in the treatment of the elderly patients with unstable intertrochanteric fractures[J]. Journal of Clinical Medicine in Practice, 2014, (9): 101-103. DOI: 10.7619/jcmp.201409030
  • Cited by

    Periodical cited type(4)

    1. 王金会,翟建丽,闫喜凤,裴强,屈自如,赵习德. 清胃降逆方联合雷贝拉唑钠肠溶胶囊治疗肝胃郁热型反流性食管炎的疗效及对G-17、PGⅠ、PGⅡ水平的影响. 中医研究. 2023(02): 26-29 .
    2. 顾丹阳,宫跃敏. 老年慢性萎缩性胃炎患者Hp感染、血清G-17、PG表达水平变化. 湖南师范大学学报(医学版). 2021(06): 124-127 .
    3. 种丽莉. 血清胃泌素17联合胃蛋白酶原检测在萎缩性胃炎诊断中的价值. 河南医学研究. 2020(27): 5146-5148 .
    4. 常晓红. 检测降钙素与血清胃蛋白酶原对在萎缩性胃炎并发幽门螺杆菌感染的诊断价值. 兵团医学. 2019(04): 1-2 .

    Other cited types(0)

Catalog

    Article views (371) PDF downloads (15) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return